- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04329455
Evaluation of Endoscopic Thyroidectomy Via Axillo-breast Approach in Thyroid Nodules (Thyroidectomy)
March 30, 2020 updated by: Ahmed Gamal Hemdan, Assiut University
Evaluation of Endoscopic Thyroidectomy via Axillo-breast Approach in Thyroid Nodules regarding safety and cosmetic outcomes
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed Mohamed Gamal, MD
- Phone Number: 71111 01069850499
- Email: ahmedgamalgeneralsurgery@gmail.com
Study Contact Backup
- Name: Ahmed Mohamed Gamal
Study Locations
-
-
-
Assiut, Egypt, 71111
- Recruiting
- Ahmed Gamal
-
Contact:
- Ahmed Mohamed Gamal
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
30 patients age group 18_55 years with unilateral or bilateral thyroid nodules benign according to preoperative FNAC and normal thyroid function
Description
Inclusion Criteria:
- benign thyroid nodules unilateral or bilateral Normal thyroid function
Exclusion Criteria:
- malignant Thyroid Nodules Recurrent goitre Toxic goitre
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Intervention group
|
Endoscopic thyroidectomy in Thyroid Nodules
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Safety of Endoscopic Thyroidectomy
Time Frame: 2020_2023
|
2020_2023
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cosmetic outcome of Endoscopic Thyroidectomy
Time Frame: 2020_2023
|
2020_2023
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2020
Primary Completion (Anticipated)
April 1, 2022
Study Completion (Anticipated)
April 1, 2023
Study Registration Dates
First Submitted
March 30, 2020
First Submitted That Met QC Criteria
March 30, 2020
First Posted (Actual)
April 1, 2020
Study Record Updates
Last Update Posted (Actual)
April 1, 2020
Last Update Submitted That Met QC Criteria
March 30, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ahmed1989
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Safety and Cosmetic Issues in Endoscopic Thyroidectomy
-
Khon Kaen UniversityUnknownQuality of Life | Transoral Endoscopic Thyroidectomy | Conventional ThyroidectomyThailand
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD); Rhode... and other collaboratorsEnrolling by invitation
-
University of California, San DiegoBaxter Healthcare Corporation; Scripps Health; Home Dialysis Therapies of San...Active, not recruitingEfficacy | Safety IssuesUnited States
-
Johns Hopkins UniversityYale University; Centers for Disease Control and Prevention; Rhode Island Hospital and other collaboratorsEnrolling by invitationSafety Issues | Firearm InjuryUnited States
-
Haukeland University HospitalUniversity of Bergen; The Research Council of Norway; Helse Vest; Western Norway...CompletedSurgery | Complication | Safety Issues | Health Literacy | Patient Safety | Health EconomicsNorway
-
CoapTechUniversity of Maryland, Baltimore; University of Maryland Medical CenterNot yet recruitingSafety Issues | Jejunostomy; Complications | Enteral and Supplement Feeds Adverse ReactionUnited States
-
Henry Ford Health SystemGebauer CompanyCompletedPain | Safety Issues | SprayUnited States
-
Danish Labor InspectorateNational Research Centre for the Working Environment, DenmarkRecruitingOccupational Diseases | Safety Issues | Occupational InjuriesDenmark
-
University of Alabama at BirminghamCompletedInjuries | Safety Issues | Firearm InjuryUnited States
Clinical Trials on Endoscopic thyroidectomy
-
Second Military Medical UniversityUnknown
-
Second Military Medical UniversityUnknown
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityActive, not recruiting
-
Khon Kaen UniversityUnknownQuality of Life | Transoral Endoscopic Thyroidectomy | Conventional ThyroidectomyThailand
-
Fujian Medical UniversityUnknownEndoscopy | Papillary Thyroid Carcinoma | Thyroidectomy | RoboticsChina
-
Sun Yat-sen UniversityCompletedPapillary Thyroid CarcinomaChina
-
Khon Kaen UniversityCompletedThyroid Neoplasms | Thyroid Cancer | Thyroid NoduleThailand
-
University Hospital, LilleMinistry of Health, FranceRecruitingLobectomy | ThyroidectomyFrance
-
Tseung Kwan O Hospital, Hong KongRecruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid NoduleHong Kong
-
Nanfang Hospital, Southern Medical UniversityRecruitingPapillary Thyroid CancerChina